Direct Dirigeants by NewCap invites you to their event

Presentation of Poxel's 2022 Full Year Results

About this event

On the occasion of the release of 2022 Half-Year results, Thomas Kuhn, Chief Executive Officer and David Moller, Executive Vice President, Chief Scientific Officerare pleased to invite you to a live webinar on Thursday, March 23rd, 2023 at 2:45pm CET/9:45am ET.


Hosted by

  • Guest speaker
    G
    Thomas Kuhn Directeur Général / CEO @ Poxel Pharma

  • Guest speaker
    G
    David Moller Executive Vice President, Chief Scientific Officer @ Poxel Pharma

Direct Dirigeants by NewCap

La plateforme d’échanges avec les dirigeants de sociétés cotées en bourse

NewCap a conçu une plateforme d’événements sur mesure pour créer, enrichir et pérenniser la relation entre les sociétés cotées et leurs actionnaires.